Pharmaceutical company CJSC ARAY announced today that it is in active research and development phase of a new Hormone Replacement Therapy (HRT) drug, called SUSTADREN (TM), housed in Bishkek, Kyrgyz Republic.
The top quality active pharmaceutical ingredients and oils are going to be used as adjuvants in the product to ensure the best quality and compliance with international standards. Thus, all delivered ingredients and substances will comply with the pharmacopoeia grade requirements, including the British (BP) and European Pharmacopoeia (EP), as well as GMP.
The Company is looking to develop and produce a number of oral and injectable drugs of hormonal origin as housed by own GMP pharmaceutical plant in Bishkek, Kyrgyz Republic in the nearest future.
Let’s block ads! (Why?)
Key takeaways:Kumaraswamy warned that Congress could push DK Shivakumar out as chief minister.DK Shivakumar’s claim…
Key takeaways:Nana Patekar has officially been cast in Nagraj Manjule's upcoming Marathi film Khashaba.All three…
Key takeaways:Zoho announced no annual pay hikes for 2024, citing rising AI and server costs.Founder…
Key takeaways:The INDIA bloc filed a Supreme Court petition challenging voter deletions made under the…
Key takeaways:Immigration agents searched Rep. Ilhan Omar’s Washington home as part of a criminal probe.Omar…
Key takeaways:Jamie Carragher publicly urged Liverpool to drop Florian Wirtz, calling the £116 million signing a…